These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 20836623

  • 1. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
    Duceppe N, Tabrizian M.
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1191-207. PubMed ID: 20836623
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P, de la Fuente M, Sánchez A, Seijo B, Alonso MJ.
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
    Wang J, Tao X, Zhang Y, Wei D, Ren Y.
    Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
    [Abstract] [Full Text] [Related]

  • 8. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q, Wang T, Cochrane C, McCarron P.
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [Abstract] [Full Text] [Related]

  • 9. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM, Li YJ, Qiu LY, Jin Y.
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
    Martien R, Loretz B, Thaler M, Majzoob S, Bernkop-Schnürch A.
    J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
    [Abstract] [Full Text] [Related]

  • 12. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ.
    Int J Pharm; 2009 Nov 03; 381(2):122-9. PubMed ID: 19467809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.
    J Control Release; 2008 May 08; 127(3):208-18. PubMed ID: 18336946
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J, Chen XG, Sun GZ, Huang L, Cheng XJ.
    Colloids Surf B Biointerfaces; 2010 Jun 01; 77(2):125-30. PubMed ID: 20172698
    [Abstract] [Full Text] [Related]

  • 18. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
    Teijeiro-Osorio D, Remuñán-López C, Alonso MJ.
    Eur J Pharm Biopharm; 2009 Feb 01; 71(2):257-63. PubMed ID: 18955137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.